Abbott Laboratories Completes Acquisition of Facet Biotech

April 22, 2010 |

1 min read

ABBOTT PARK, Ill., April 21 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT - News) has completed its acquisition of Facet Biotech Corporation, strengthening its pharmaceutical pipeline in immunology and oncology.

Mergers & acquisitions

Abbott Laboratories

MORE ON THIS TOPIC

Group of blue paper boats following on red on yellow background, mass manipulation

Mergers & acquisitions

How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio

October 2, 2025

·

3 min read

·

Annalee Armstrong

Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.

Mergers & acquisitions

Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together

October 2, 2025

·

2 min read

·

Tristan Manalac

Podcast

M&A Picks Up, Walmsley Moves On, Pfizer’s MFN Deal and Hope for Huntington’s

October 1, 2025

·

2 min read

·

Heather McKenzie

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Mergers & acquisitions

Genmab Buys Rising Cancer Star Merus for $8B

September 29, 2025

·

2 min read

·

Tristan Manalac